Latest Infectious Disease News
BNT162b2 Vaccine Effectiveness 92 Percent for Teens Ages 12 to 17
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adverse Events Rare After BNT162b2 Vaccine in 5- to 11-Year-Olds
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA May Allow Pfizer Boosters for 12- to 15-Year-Olds by Monday
posted December 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
WMS Issues Guidelines on Tickborne Illness in the U.S.
posted December 29th
by modernClinician Editorial Team
by modernClinician Editorial Team
CDC: 1,955 Arboviral Disease Cases Reported in 48 States, D.C. in 2024
CDC: Seroprevalence of Alpha-Gal IgE Antibodies Highest in States With Elevated Case Counts
1,173 Cases of Domestic Arboviral Disease Reported in 2019 in United States
Mean Cumulative Incidence of Tick Bite ED Visits 49 Per 100,000
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season
About 1 in 20 Hospitalized U.S. Adults With Firearm Injuries Develop Bacterial Infections